R. Colin Garner

6.1k citations
121 papers · 4.6k indexed · h-index 42
Topics
Carcinogens and Genotoxicity Assessment (47 papers)Mycotoxins in Agriculture and Food (24 papers)Pharmacogenetics and Drug Metabolism (16 papers)

In The Last Decade

R. Colin Garner

116 papers receiving 4.2k citations

Peers

R. Colin Garner
Comparison fields: 5 of 138
  • Cancer Research 1.8k
  • Molecular Biology 1.7k
  • Plant Science 1.1k
  • Pharmacology 845
  • Health, Toxicology and Mutagenesis 674
Replace Elizabeth K. Weisburger with:
Elizabeth K. Weisburger United States
James S. Felton United States
P.L. Grover United Kingdom
Peter B. Farmer United Kingdom
Robert H. Heflich United States
Werner K. Lutz Switzerland
Alan Hewer United Kingdom
William Lijinsky United States
P. David Josephy Canada
C. Malaveille France
R. Colin Garner relative to Elizabeth K. Weisburger United States Elizabeth K. Weisburger's profile →
Citations per field
00.5×4.9×
Elizabeth K. Weisburger · 1×
Citations per year

Countries citing papers authored by R. Colin Garner

Since Specialization
Citations

This map shows the geographic impact of R. Colin Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Colin Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Colin Garner more than expected).

Fields of papers citing papers by R. Colin Garner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Colin Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Colin Garner. The network helps show where R. Colin Garner may publish in the future.

Co-authorship network of co-authors of R. Colin Garner

This figure shows the co-authorship network connecting the top 25 collaborators of R. Colin Garner. A scholar is included among the top collaborators of R. Colin Garner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Colin Garner. R. Colin Garner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 61
2 36
3 57
4 51
5 49
6 3
7 47
8
環境曝露用量でのアルブミンとヘモグロビンへの2‐アミノ3,8‐ジメチルイミダゾ[4,5‐f]キノキサリンの共有結合 ヒトとF344ラットの比較
0
9 9
10 2
11 19
12
Human carcinogen exposure : biomonitoring and risk assessment
23
13 5
14 95
15
Structural characterization of the major adducts obtained after reaction of an ultimate carcinogen aflatoxin B1-dichloride with calf thymus DNA in vitro.
5
16 10
17 36
18
Testing of known carcinogens and noncarcinogens for their ability to induce unscheduled DNA synthesis in HeLa cells.
195
19 155
20 1

About R. Colin Garner

R. Colin Garner is a scholar working on Cancer Research, Chemical Health and Safety and Pharmacology, having authored 121 papers that have together received 4.6k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (47 papers), Mycotoxins in Agriculture and Food (24 papers) and Pharmacogenetics and Drug Metabolism (16 papers). The work is most often cited by research in Cancer Research (1.8k citations), Pharmacology (845 citations) and Chemical Health and Safety (36 citations). R. Colin Garner has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Graham Lappin, Carl N. Martin, Elizabeth C. Miller, James A. Miller, A.E.M. McLean, John R. Lindsay Smith, Paul J. Hertzog, Kenneth W. Turteltaub, Karen H. Dingley and K. Norpoth. Their work appears in journals such as Nature, Journal of Clinical Oncology and Nature Reviews Drug Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026